BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28025927)

  • 1. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.
    Park T; Jung J
    J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?
    Mott DA; Thorpe JM; Thorpe CT; Kreling DH; Gadkari AS
    Res Social Adm Pharm; 2010 Jun; 6(2):90-9. PubMed ID: 20511108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year impact of Medicare Part D coverage gap reform on drug expenditures and utilization.
    Park J; Look KA
    Health Serv Res; 2022 Feb; 57(1):56-65. PubMed ID: 33870486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.
    Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM
    Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
    Bonakdar Tehrani A; Cunningham PJ
    Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.
    McGee BT; Phillips V; Higgins MK; Butler J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):705-713. PubMed ID: 31134861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Medicare Part D on drug and medical spending.
    Zhang Y; Donohue JM; Lave JR; O'Donnell G; Newhouse JP
    N Engl J Med; 2009 Jul; 361(1):52-61. PubMed ID: 19571283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
    Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
    J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
    McWilliams JM; Zaslavsky AM; Huskamp HA
    JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities.
    Nelson RE; Nelson SL; Huttner B; Gundlapalli A
    Disabil Health J; 2014 Jan; 7(1):64-9. PubMed ID: 24411509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Medicare part D on income-related inequality in pharmaceutical expenditure.
    Carvalho N; Petrie D; Chen L; Salomon JA; Clarke P
    Int J Equity Health; 2019 Apr; 18(1):57. PubMed ID: 30992000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket Cap.
    Trish E; Xu J; Joyce G
    Health Aff (Millwood); 2018 Jul; 37(7):1048-1056. PubMed ID: 29985706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019.
    Dusetzina SB; Huskamp HA; Qin X; Keating NL
    JAMA; 2022 Oct; 328(15):1515-1522. PubMed ID: 36255428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2015 Oct; 21(10):956-64. PubMed ID: 26402394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase.
    Trish E; Xu J; Joyce G
    Health Aff (Millwood); 2016 Sep; 35(9):1564-71. PubMed ID: 27605634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007.
    Briesacher BA; Zhao Y; Madden JM; Zhang F; Adams AS; Tjia J; Ross-Degnan D; Gurwitz JH; Soumerai SB
    Med Care; 2011 Sep; 49(9):834-41. PubMed ID: 21544002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.